PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.20%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-18.65%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-21.71%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-21.71%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-60.51%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-60.19%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-60.13%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.95%
Share reduction while MTDR is at 0.44%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.13%
Reduced diluted shares while MTDR is at 0.24%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
3.19%
Dividend growth above 1.5x MTDR's 0.18%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-49.79%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-90.09%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-27.22%
Negative 10Y revenue/share CAGR while MTDR stands at 482.42%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
83.80%
5Y revenue/share CAGR under 50% of MTDR's 326.20%. Michael Burry would suspect a significant competitive gap or product weakness.
31.49%
3Y revenue/share CAGR under 50% of MTDR's 187.14%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-61.60%
Negative 10Y OCF/share CAGR while MTDR stands at 704.74%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
12.84%
Below 50% of MTDR's 646.42%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-23.15%
Negative 3Y OCF/share CAGR while MTDR stands at 169.88%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
60.11%
Below 50% of MTDR's 549.56%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
224.97%
Below 50% of MTDR's 1178.78%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
5.49%
Below 50% of MTDR's 211.67%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
7.74%
Below 50% of MTDR's 313.38%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-10.27%
Negative 5Y equity/share growth while MTDR is at 146.59%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
139.40%
3Y equity/share CAGR at 50-75% of MTDR's 217.11%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-13.80%
Cut dividends over 10 years while MTDR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
158.81%
Dividend/share CAGR of 158.81% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
221.47%
Below 50% of MTDR's 699.08%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-3.27%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-0.77%
Negative asset growth while MTDR invests at 5.95%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.09%
We have a declining book value while MTDR shows 11.82%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
6.42%
We have some new debt while MTDR reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
2.27%
SG&A growth well above MTDR's 0.54%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.